IceCure Medical Management
Management criteria checks 4/4
IceCure Medical's CEO is Eyal Shamir, appointed in Sep 2016, has a tenure of 7.67 years. total yearly compensation is $553.00K, comprised of 75.3% salary and 24.7% bonuses, including company stock and options. directly owns 1.14% of the company’s shares, worth $609.15K. The average tenure of the management team and the board of directors is 5.4 years and 6.4 years respectively.
Key information
Eyal Shamir
Chief executive officer
US$553.0k
Total compensation
| CEO salary percentage | 75.3% |
| CEO tenure | 7.7yrs |
| CEO ownership | 1.1% |
| Management average tenure | 5.4yrs |
| Board average tenure | 6.4yrs |
Recent management updates
Recent updates
We're Keeping An Eye On IceCure Medical's (NASDAQ:ICCM) Cash Burn Rate
Nov 29
Is IceCure Medical (NASDAQ:ICCM) In A Good Position To Deliver On Growth Plans?
Aug 08IceCure gains 19% on seeking FDA nod for cancer treatment
Oct 19IceCure files application for approval of ProSense in Canada for tumors
Jul 25IceCure Medical: Advancing Cryotherapy For Cancer Treatment
Jan 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$553k | US$416k | -US$15m |
| Sep 30 2023 | n/a | n/a | -US$16m |
| Jun 30 2023 | n/a | n/a | -US$16m |
| Mar 31 2023 | n/a | n/a | -US$16m |
| Dec 31 2022 | US$658k | US$467k | -US$17m |
| Sep 30 2022 | n/a | n/a | -US$16m |
| Jun 30 2022 | n/a | n/a | -US$15m |
| Mar 31 2022 | n/a | n/a | -US$13m |
| Dec 31 2021 | US$489k | US$426k | -US$10m |
| Sep 30 2021 | n/a | n/a | -US$8m |
| Jun 30 2021 | n/a | n/a | -US$6m |
| Mar 31 2021 | n/a | n/a | -US$4m |
| Dec 31 2020 | US$420k | US$370k | -US$4m |
| Sep 30 2020 | n/a | n/a | -US$4m |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | n/a | n/a | -US$4m |
| Dec 31 2019 | n/a | n/a | -US$5m |
| Sep 30 2019 | n/a | n/a | -US$5m |
| Jun 30 2019 | n/a | n/a | -US$4m |
| Mar 31 2019 | n/a | n/a | -US$4m |
| Dec 31 2018 | US$350k | US$251k | -US$4m |
| Sep 30 2018 | n/a | n/a | -US$3m |
| Jun 30 2018 | n/a | n/a | -US$3m |
| Mar 31 2018 | n/a | n/a | -US$3m |
| Dec 31 2017 | US$312k | US$259k | -US$3m |
Compensation vs Market: Eyal's total compensation ($USD553.00K) is about average for companies of similar size in the US market ($USD663.50K).
Compensation vs Earnings: Eyal's compensation has been consistent with company performance over the past year.
CEO
Eyal Shamir (62 yo)
7.7yrs
Tenure
US$552,996
Compensation
Mr. Eyal Shamir serves as Chief Executive Officer and Director at IceCure Medical Ltd. since September 2016 and December 2017 respectively. Mr. Shamir served as Chief Executive Officer of Tadbik Pack Ltd.,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 7.7yrs | US$553.00k | 1.14% $ 609.2k | |
| CFO & COO | 7yrs | US$405.26k | 0.67% $ 359.8k | |
| Vice President of Business Development & Global Marketing | 5.4yrs | US$320.70k | 0.34% $ 183.1k | |
| Vice President of Human Resources | 2.5yrs | US$282.17k | 0.13% $ 68.0k | |
| Vice President of Operations & Service | 1.4yrs | no data | 0.12% $ 65.9k |
5.4yrs
Average Tenure
54yo
Average Age
Experienced Management: ICCM's management team is seasoned and experienced (5.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 6.4yrs | US$553.00k | 1.14% $ 609.2k | |
| Independent Director | 11.8yrs | no data | no data | |
| Independent External Director | 4.7yrs | US$205.58k | no data | |
| Independent External Director | 10.7yrs | no data | 0.022% $ 11.7k | |
| Chairman of the Board | 6.4yrs | US$62.23k | 0.49% $ 260.4k | |
| Independent Director | 1.4yrs | no data | no data | |
| Director | 4.1yrs | no data | 0.16% $ 85.8k |
6.4yrs
Average Tenure
60yo
Average Age
Experienced Board: ICCM's board of directors are considered experienced (6.4 years average tenure).